J2 Interactive Blog
J2 covers a wide range of topics related to healthcare IT, interoperability, and CRM for healthcare and life sciences organizations.
Healthcare Digital Marketing For New Patient Acquisition
July 31st, 2018
Many healthcare organizations are looking to increase their new patient acquisition rate via digital marketing efforts. For healthcare digital marketing to be effective, it is important that the patient journey is mirrored by internal processes and the right mix of digital systems. Rather than write in high level terms about a patient journey, I though […]
What’s New With FHIR? News from HL7 FHIR Dev Days
June 29th, 2018
The first HL7 FHIR Developer Days conference held in the Americas just wrapped up. Today’s guest blog is by J2 subject matter expert Ayesha Lefebvre. She attended the conference in Boston last week and wrote about her favorite takeaways.
Why We’re Excited About InterSystems IRIS
June 25th, 2018
Director of Innovation at J2 Interactive, Steve Heard, takes us through some of the exciting elements in the InterSystems IRIS Data Platform, the new way of leveraging data that’s more scalable and simpler to maintain than anything we’ve seen before.
Post Acute Care In The Home: Technological Advances
May 23rd, 2018
Post-acute care continues to be a rapidly growing segment within healthcare. The growth has been driven both by economics and by technological innovation. On the economics front, insurance companies and Medicare have reduce reimbursements for readmissions that occur shortly (10 – 31 days) after a patient has been discharged. Beginning in October 2012, the Hospital Readmissions Reduction Program required the Centers for Medicare and Medicaid Services (CMS) to reduce payments to inpatient prospective payment system (IPPS) hospitals with excess readmissions. […]
Integrating the PDMP into the Provider Workflow in Rhode Island
April 16th, 2018
Like many states across the country, Rhode Island is working to address the opioid addiction epidemic. Also like other states, Rhode Island runs a Prescription Drug Monitoring Program (PDMP) as one strategy to mitigate the crisis.
How CRM Can Help Medical Device Manufacturers With CAPA Procedures
March 12th, 2018
The FDA’s Title 21 CFR 820 Regulatory Requirement means that manufacturers of medical devices that are subject to FDA regulation need to establish and maintain procedures for implementing corrective and preventive action (CAPA) related to device non-conformity. These procedures must provide for control and action to be taken on any distributed or not yet distributed […]